Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 36% ± 16% | |
peripheral blood | 16 studies | 37% ± 10% | |
intestine | 10 studies | 32% ± 15% | |
kidney | 7 studies | 36% ± 4% | |
liver | 7 studies | 27% ± 16% | |
eye | 6 studies | 26% ± 13% | |
lymph node | 5 studies | 37% ± 12% | |
brain | 5 studies | 25% ± 6% | |
pancreas | 4 studies | 56% ± 19% | |
uterus | 4 studies | 37% ± 16% | |
breast | 4 studies | 28% ± 7% | |
placenta | 3 studies | 39% ± 19% | |
bone marrow | 3 studies | 26% ± 6% | |
adrenal gland | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10510.82 | 1445 / 1445 | 100% | 219.06 | 183 / 183 |
ovary | 100% | 6324.87 | 180 / 180 | 100% | 283.89 | 430 / 430 |
pancreas | 100% | 6369.34 | 328 / 328 | 100% | 171.76 | 178 / 178 |
skin | 100% | 11020.37 | 1809 / 1809 | 100% | 311.11 | 471 / 472 |
uterus | 100% | 6615.89 | 170 / 170 | 100% | 211.45 | 458 / 459 |
stomach | 100% | 8071.56 | 359 / 359 | 100% | 292.13 | 285 / 286 |
intestine | 100% | 10589.86 | 966 / 966 | 100% | 329.95 | 525 / 527 |
prostate | 100% | 6923.55 | 245 / 245 | 99% | 251.73 | 499 / 502 |
thymus | 100% | 6844.09 | 651 / 653 | 100% | 156.12 | 603 / 605 |
liver | 100% | 11824.23 | 225 / 226 | 100% | 226.13 | 405 / 406 |
breast | 100% | 7722.01 | 459 / 459 | 99% | 215.81 | 1107 / 1118 |
kidney | 100% | 10546.42 | 89 / 89 | 99% | 177.13 | 891 / 901 |
lung | 99% | 6606.95 | 573 / 578 | 99% | 218.52 | 1149 / 1155 |
bladder | 100% | 8634.52 | 21 / 21 | 99% | 246.14 | 497 / 504 |
adrenal gland | 100% | 16111.86 | 258 / 258 | 98% | 187.22 | 225 / 230 |
brain | 97% | 6510.20 | 2554 / 2642 | 100% | 202.40 | 705 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 280.08 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 275.20 | 29 / 29 |
muscle | 100% | 36503.38 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7322.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 216.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 88.45 | 1 / 1 |
adipose | 100% | 7598.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7051.50 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 21242.28 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 6497.70 | 792 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006108 | Biological process | malate metabolic process |
GO_0009060 | Biological process | aerobic respiration |
GO_0006734 | Biological process | NADH metabolic process |
GO_0006107 | Biological process | oxaloacetate metabolic process |
GO_0006094 | Biological process | gluconeogenesis |
GO_0006099 | Biological process | tricarboxylic acid cycle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0046554 | Molecular function | L-malate dehydrogenase (NADP+) activity |
GO_0030060 | Molecular function | L-malate dehydrogenase (NAD+) activity |
Gene name | MDH2 |
Protein name | Malate dehydrogenase, mitochondrial (EC 1.1.1.37) Malate dehydrogenase (EC 1.1.1.37) Malate dehydrogenase 2 Uncharacterized protein MDH2 |
Synonyms | hCG_1818102 |
Description | |
Accessions | ENST00000432020.2 [P40926-2] ENST00000443006.5 ENST00000315758.10 [P40926-1] ENST00000461263.2 Q75MT9 Q75MP7 P40926 Q6FHZ0 G3XAL0 U3KQ63 Q0QF37 |